Insulin Antibody

This is a single-marker test measuring the presence of antibodies against insulin in the blood. It is particularly useful in patients who have not yet been treated with insulin but present with symptoms suggestive of diabetes or have a family history of the condition. This test aids in differentiating between type 1 diabetes mellitus (autoimmune), type 2 diabetes mellitus, and atypical forms like latent autoimmune diabetes in adults (LADA). It is also valuable in assessing the risk of future type 1 diabetes and in diagnosing rare autoimmune hypoglycemic syndromes.

This is a single-marker test measuring the presence of antibodies against insulin in the blood. It is particularly useful in patients who have not yet been treated with insulin but present with symptoms suggestive of diabetes or have a family history of the condition. This test aids in differentiating between type 1 diabetes mellitus (autoimmune), type 2 diabetes mellitus, and atypical forms like latent autoimmune diabetes in adults (LADA). It is also valuable in assessing the risk of future type 1 diabetes and in diagnosing rare autoimmune hypoglycemic syndromes.

Diabetes Autoimmune Profile - The Diabetes Autoimmune Profile is used to identify patients at risk for developing type 1 diabetes.

Insulin Autoantibody - In patients who have not yet been treated with insulin but have symptoms suggestive of diabetes or a genetic predisposition based on family history, this test can be used to 1) distinguish among type 1 diabetes mellitus (autoimmune), type 2 diabetes mellitus, and atypical forms of diabetes, such as latent autoimmune diabetes in adults (LADA); or 2) to evaluate risk of future type 1 diabetes. This test may also be useful when evaluating patients for very rare autoimmune hypoglycemic syndrome. In patients who have already been treated with insulin, insulin autoantibodies are usually of no clinical significance. Therefore, insulin antibody testing is generally not indicated for these patients.

The Diabetes Autoimmune Profile is used to identify patients at risk for developing type 1 diabetes.